Teva Sues Perrigo Over Patents for ProAir Asthma Inhaler

A unit of Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, sued rival Perrigo Co. over patents for the ProAir asthma inhaler.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.